Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Strategic Partnership

10 Jun 2013 07:00

RNS Number : 6083G
Ideagen PLC
10 June 2013
 



 

Ideagen plc

("Ideagen" or the "Company")

 

Strategic Partnership with a Leading Global Medical Device Manufacturer

 

Ideagen PLC (AIM: IDEA), a leading supplier of Compliance based Information Management solutions is pleased to announce that it has signed a strategic partnership with a leading global manufacturer of medical devices to supply the company's order communications software, dartOCM, into the UK NHS.

 

DartOCM is an application platform which provides context related intelligent information management of pathology services for both hospitals and GP clinicians. The solution enables the ordering of appropriate tests while delivering "paperless" results back to the clinician with real time notifications and alerts in a centralised patient record.

 

The UK NHS is currently undergoing a consolidation of its pathology services in line with the Carter report (2008), which stated that reform was key and could deliver ÂŁ500m savings annually whilst improving service levels. "Consolidation of pathology services into reconfigured networks will improve services for patients by enhancing value for money and releasing resources for investment to improve service quality and patient safety". To date 2 regional networks have been announced with additional regions expected to be announced over the next year.

 

The partnership has resulted in an immediate ÂŁ150k contract to supply the dartOCM system to an Acute Trust in the Midlands, which will be used as a 'lighthouse' pilot to demonstrate the compelling value proposition of the solution in terms of both operational and financial benefits. It is expected that, if successful, the planned regional roll out will generate a significant, multi-year contract for Ideagen supporting 10,000 users across 700 sites, and provide a strong reference to accelerate further roll-outs in to new networks across the country.

 

David Hornsby Chief Executive said: ''I am delighted that we have been selected to support this important programme for the NHS. There is a significant market opportunity to provide dartOCM to streamline the test and results process in supporting the consolidation of pathology services within the NHS. To be selected as the preferred technology platform by a global leader in the field of medical diagnostic equipment is a testament to our prominent position in this area''

Enquiries:

Ideagen Plc

Tel: 01629 761590

David Hornsby, Chief Executive

Graeme Spenceley, Finance Director

finnCap (Nominated Adviser and Broker)

Tel: 020 7220 0500

Matt Goode/ Charlotte Stranner (Corporate Finance)

Stephen Norcross (Corporate Broking)

Walbrook PR Ltd

Tel: 020 7933 8780

Helen Westaway

Helen.westaway@walbrookpr.com

Paul Cornelius

Paul.cornelius@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKODQPBKDBAK
Date   Source Headline
1st Jul 202211:27 amRNSForm 8.5 (EPT/RI)
30th Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
30th Jun 20221:38 pmRNSForm 8.3 -IDEAGEN PLC
30th Jun 202211:03 amGNWForm 8.3 - Ideagen PLC
30th Jun 20229:57 amRNSForm 8.5 (EPT/RI)
29th Jun 20224:00 pmRNSHolding(s) in Company
29th Jun 20223:30 pmRNSForm 8.3 - Ideagen Plc
29th Jun 20223:30 pmRNSForm 8.3 - IDEA LN
29th Jun 20223:30 pmGNWForm 8.3 - Ideagen plc
29th Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
29th Jun 20222:04 pmRNSForm 8.3 - Ideagen plc
29th Jun 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
29th Jun 202211:48 amRNSForm 8.5 (EPT/RI)
29th Jun 20227:00 amRNSHolding(s) in Company
28th Jun 20223:30 pmRNSForm 8.3 - IDEA LN
28th Jun 20223:11 pmBUSForm 8.3 - Ideagen Plc
28th Jun 20223:00 pmRNSForm 8.3 - Ideagen PLC
28th Jun 202212:37 pmGNWForm 8.3 - [Ideagen plc - 28 06 2022] - (CGWL)
28th Jun 202212:20 pmRNSForm 8.3 - Ideagen plc
28th Jun 202210:00 amRNSHolding(s) in Company
27th Jun 20223:29 pmRNSForm 8.3 - Ideagen plc
27th Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
27th Jun 20222:45 pmRNSForm 8.3 - Ideagen PLC
27th Jun 202212:53 pmRNSForm 8.3 - Ideagen plc
27th Jun 202211:28 amRNSForm 8.5 (EPT/RI)
27th Jun 202211:10 amRNSForm 8.3 - IDEAGEN PLC
24th Jun 20225:03 pmRNSForm 8.3 - Ideagen plc Amendment
24th Jun 20223:30 pmBUSForm 8.3 - Ideagen plc
24th Jun 20223:30 pmGNWForm 8.3 - Ideagen plc
24th Jun 20223:03 pmRNSForm 8.3 - Ideagen Plc
24th Jun 20223:00 pmRNSForm 8.3 - Ideagen Plc
24th Jun 20221:19 pmRNSForm 8.3 - Ideagen plc
24th Jun 20221:06 pmRNSForm 8.3 - Ideagen Plc
24th Jun 202211:24 amRNSForm 8.5 (EPT/RI)
24th Jun 202210:10 amRNSForm 8.5 (EPT/RI)
24th Jun 20228:17 amRNSForm 8.5 (EPT/RI) - Amendment
23rd Jun 20226:35 pmRNSResults of Court Meeting and General Meeting
23rd Jun 20223:32 pmRNSForm 8.3 - Ideagen Plc
23rd Jun 20223:30 pmBUSForm 8.3 - Ideagen plc
23rd Jun 20223:30 pmGNWForm 8.3 - Ideagen plc
23rd Jun 20223:20 pmRNSForm 8.3 - Ideagen plc
23rd Jun 20223:16 pmRNSForm 8.3 - IDEAGEN PLC - AMENDMENT
23rd Jun 20222:45 pmRNSForm 8.3 - Ideagen PLC
23rd Jun 20222:30 pmRNSHolding(s) in Company
23rd Jun 20221:16 pmGNWForm 8.3 - Ideagen PLC
23rd Jun 202211:54 amRNSForm 8.3 - IDEAGEN PLC
23rd Jun 202211:41 amRNSForm 8.3 - Ideagen plc
23rd Jun 202211:21 amRNSForm 8.5 (EPT/RI)
23rd Jun 20228:42 amRNSForm 8.5 (EPT/RI)
22nd Jun 20225:59 pmRNSForm 8.3 - IDEA LN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.